Pembroke Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.21M Buy
21,884
+5,941
+37% +$966K 0.52% 50
2026
Q2
$2.18M Buy
+15,943
New +$1.96M 0.28% 56
2024
Q2
– Sell
-63,232
Closed -$11.6M – 65
2024
Q1
$11.6M Sell
63,232
-2,141
-3% -$408K 1.37% 33
2023
Q4
$11.8M Buy
65,373
+23,976
+58% +$3.73M 1.46% 30
2023
Q3
$6.58M Sell
41,397
-3,959
-9% -$647K 0.9% 43
2023
Q2
$6.42M Buy
45,356
+7,919
+21% +$1.27M 0.69% 46
2023
Q1
$6.3M Sell
37,437
-2,983
-7% -$532K 0.69% 45
2022
Q4
$6.84M Buy
40,420
+8,435
+26% +$1.53M 0.73% 47
2022
Q3
$5.98M Sell
31,985
-652
-2% -$137K 0.66% 47
2022
Q2
$5.3M Buy
+32,637
New +$5.16M 0.55% 52

Other funds holding RGEN

Pembroke Management's RGEN Position: Q3 2026 in Review

Pembroke Management increased its Repligen (RGEN) stake by 37% in Q3 2026, buying an estimated $966K and bringing the position to 21,884 shares worth $4.21M. The position accounts for 0.52% of the portfolio, ranked #50.

Pembroke Management first reported a position in RGEN in Q2 2022 and has held it in 10 quarters since. The position peaked at $11.8M in Q4 2023. 277 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Pembroke Management held 21,884 shares of Repligen worth $4.21M as of Q3 2026.
  • Pembroke Management bought 5,941 Repligen shares in Q3 2026, an estimated $966K.
  • Repligen made up 0.52% of Pembroke Management's portfolio in Q3 2026, its #50 holding.
  • Pembroke Management first reported a position in Repligen in Q2 2022 and has held it in 10 quarters since.
  • Pembroke Management's Repligen position peaked at $11.8M in Q4 2023.
  • 277 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Pembroke Management's 13F filing for Q3 2026, filed 21 Oct 2026.